Autologous Stem Cells therapy(Apeiron Research Center)

N/A

Report date: 2025/03/06 20:00:09

Base Information

Drug NameAutologous Stem Cells therapy(Apeiron Research Center)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derived

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsParkinson DiseaseParkinsonian Disorders

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesApeiron Research Center

China Registration ClassN/A

Develop Information

Active CompaniesApeiron Research Center

Inactive CompaniesN/A

Active IndicationsParkinson DiseaseParkinsonian Disorders

Inactive IndicationsN/A

Other Information

ATC CodeN/A